Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |